Filing Details

Accession Number:
0001209191-20-062100
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-07 21:32:12
Reporting Period:
2020-12-03
Accepted Time:
2020-12-07 21:32:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Nutrition Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472187 Edi Hienrich 800 W. Olympic Blvd. Suite 406
Los Angeles CA 90015
Svp/Managing Director Emea No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-03 15,000 $23.90 48,529 No 4 M Direct
Common Stock Disposition 2020-12-03 10,872 $49.72 37,657 No 4 F Direct
Common Stock Acquisiton 2020-12-03 26,872 $31.26 64,529 No 4 M Direct
Common Stock Disposition 2020-12-03 21,584 $49.72 42,945 No 4 F Direct
Common Stock Disposition 2020-12-04 6,241 $49.88 36,704 No 4 S Direct
Common Stock Disposition 2020-12-07 9,416 $49.88 27,288 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2020-12-03 15,000 $0.00 15,000 $23.90
Common Stock Stock Appreciation Rights Disposition 2020-12-03 26,872 $0.00 26,872 $31.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-05-07 2025-05-07 No 4 M Direct
0 2019-05-09 2026-05-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,819 Indirect By wife
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $49.87 to $49.88. The price reported reflects the weighted average sale price of $49.8756. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as part of an award covering 12,500 shares at an exercise price of $47.80 per share.
  3. The SARs were granted on May 7, 2015. 20% vested on May 7, 2016, 20% vested on May 7, 2017 and the remaining 60% vested on May 7, 2018.
  4. Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as part of an award covering 16,795 shares at an exercise price of $62.51 per share.
  5. The SARs were granted on May 9, 2016. 20% vested on May 9, 2017, 20% vested on May 9, 2018 and the remaining 60% vested on May 9, 2019.